Back

A novel causative gene variant, TNFRSF13B p.Gly76Ser, in patients with pulmonary arterial hypertension

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Burning News from Pulmonary Vascular Disease Pulmonary Hypertension ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Yoshiki Shinya

Keio University School of Medicine, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Endothelial cell premature senescence exacerbates pulmonary arterial hypertension through contact-mediated interaction with vascular smooth muscle cells.
Doctor R. Ramadhiani (Kobe, JP)
Abstract Slides Video
Presentation thumbnail
Contribution of peptidyl prolyl isomerase (Pin1) to development of pulmonary hypertension via pulmonary vascular endothelial cell dysfunction
Professor S. Sakai (Tsukuba, JP)
Abstract Slides Video
Presentation thumbnail
Kynurenine-PARP 1 link mediated by microRNA 210 may be dysregulated in pulmonary hypertension
Associate Professor Y. Yaylali (Denizli, TR)
Abstract Slides Video
Presentation thumbnail
Nerve growth factor receptor is involved in maintaining homeostasis of pulmonary arterial hypertension
Doctor C. Goten (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Statins for venous thromboembolism prevention: old dog, new tricks
Doctor J. Sousa (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Burning News from Pulmonary Vascular Disease

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources